Primary Site >> Colorectal Cancer
Gene >> EYA4
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection. PMID: 16670426 |
Ref: Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations. PMID: 21298349 Ref: Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. PMID: 21400501 |
Ref: Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease. PMID: 23347191 Ref: Serum methylation levels of TAC1. SEPT9 and EYA4 as diagnostic markers for early colorectal cancers: a pilot study. PMID: 23862763 Ref: Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect. PMID: 23867875 Ref: Toward a comprehensive and systematic methylome signature in colorectal cancers. PMID: 23975090 |
Ref: EYA4 Acts as a New Tumor Suppressor Gene in Colorectal Cancer. PMID: 25620232 |
Ref: Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer. PMID: 28351398 Ref: DNA methylation patterns in ulcerative colitis-associated cancer: a systematic review. PMID: 28621161 Ref: Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. PMID: 28982739 |
Ref: Promoter Hypermethylation of the Eyes Absent 4 Gene is a Tumor-Specific Epigenetic Biomarker in Iranian Colorectal Cancer Patients. PMID: 29436791 Ref: New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients. PMID: 30099509 |